Parameter

 

Total patients

Early

Advanced

 

 

N (%)

N (%)

N (%)

Age (Years)

≤ 40

28(23.73)

11(26.19)

17(22.37)

 

41 – 60 

80(67.80)

28(66.67)

52(68.42)

 

>60

10(8.47)

03(7.14)

07(9.21)

Menopausal status

Premenopausal

47(39.83)

16(38.09)

31(40.79)

 

Perimenopausal

19(16.10)

03(7.14)

16(21.05)

 

Postmenopausal

52(44.07)

23(54.76)

29(38.16)

Nodal status

Node Negative

53(44.92)

38(90.48)

15(19.74)

 

Node positive

65(55.08)

04(9.52)

61(80.26)

Histologic Type

Ductal Carcinoma

101(85.59)

35(83.33)

66(86.84)

 

Lobular Carcinoma

04(3.39)

02(4.76)

02(2.63)

 

Others

13(11.02)

05(11.90)

08(10.52)

Histologic Grade

Well Differentiation

18(15.25)

11(26.19)

07(9.21)

 

Moderate+poor Differentiation

100(84.75)

31(73.81)

69(90.79)

Stromal Involvement

Absent

02(1.69)

00

02(2.63)

 

Present

116(98.31)

42(100.0)

74(97.38)

 

+

63(54.31)

21(50.00)

42(56.76)

 

++

42(36.21)

15(35.71)

27(36.48)

 

+++

11(9.48)

06(14.29)

05(6.76)

N=Number of patients; %=Percentage

Table 1: Clinical, Pathological characteristics of 118 breast cancer patients.